Plasticity of NK cells in Cancer.
Innate lymphoid cell (ILC)
Natural killer cell
cancer immunotherapies
decidual NK cell (dNK)
intra-epithelial ILC1 (ieILC1)
tissue-resident NK cell
tumor microenvironment
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
03
2022
accepted:
12
04
2022
entrez:
27
5
2022
pubmed:
28
5
2022
medline:
31
5
2022
Statut:
epublish
Résumé
Natural killer (NK) cells are crucial to various facets of human immunity and function through direct cytotoxicity or
Identifiants
pubmed: 35619715
doi: 10.3389/fimmu.2022.888313
pmc: PMC9127295
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
888313Informations de copyright
Copyright © 2022 Corvino, Kumar and Bald.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Nat Med. 2018 Aug;24(8):1178-1191
pubmed: 29942093
J Natl Cancer Inst. 2014 Sep 01;106(8):dju200
pubmed: 25178695
Cancer Immunol Immunother. 2017 Apr;66(4):537-548
pubmed: 28184969
Int Immunopharmacol. 2015 Dec;29(2):635-641
pubmed: 26428847
J Clin Invest. 2013 Apr;123(4):1444-56
pubmed: 23524967
Cell. 2016 Jan 28;164(3):365-77
pubmed: 26806130
J Immunol. 2013 Apr 15;190(8):3939-48
pubmed: 23487420
Ann Transl Med. 2019 Mar;7(5):105
pubmed: 31019955
Semin Immunol. 2019 Feb;41:101273
pubmed: 30979591
Immunol Cell Biol. 2017 Apr;95(4):347-355
pubmed: 28138156
J Immunol. 2004 Jun 15;172(12):7335-40
pubmed: 15187109
Nat Immunol. 2011 Jun;12(6):492-9
pubmed: 21739672
Cancer Res. 2011 Aug 15;71(16):5412-22
pubmed: 21708957
Nat Rev Immunol. 2020 Sep;20(9):552-565
pubmed: 32107466
J Immunother Cancer. 2020 Dec;8(2):
pubmed: 33323462
Oncoimmunology. 2016 Dec 7;6(1):e1264562
pubmed: 28197391
Cell. 2020 Feb 20;180(4):749-763.e13
pubmed: 32059780
Eur J Immunol. 2016 Sep;46(9):2095-8
pubmed: 27600673
Front Immunol. 2017 Jun 28;8:760
pubmed: 28702032
Nat Rev Immunol. 2013 Feb;13(2):145-9
pubmed: 23348417
Clin Sci (Lond). 2021 Jan 15;135(1):35-52
pubmed: 33399850
Cell. 2018 Aug 23;174(5):1054-1066
pubmed: 30142344
J Immunother Cancer. 2021 Jul;9(7):
pubmed: 34244307
Eur J Immunol. 2016 Sep;46(9):2111-20
pubmed: 27485474
Leukemia. 2016 Apr;30(4):800-11
pubmed: 26621337
Br J Cancer. 2006 Jan 30;94(2):239-46
pubmed: 16404434
Adv Immunol. 2020;147:61-88
pubmed: 32981635
Neoplasia. 2013 Feb;15(2):133-42
pubmed: 23441128
Blood. 2006 Dec 15;108(13):4118-25
pubmed: 16902152
Hum Pathol. 2012 Mar;43(3):339-49
pubmed: 21840566
Trends Immunol. 2010 Nov;31(11):401-6
pubmed: 20829113
Immunol Rev. 2017 Nov;280(1):126-148
pubmed: 29027218
Clin Cancer Res. 2019 Jul 15;25(14):4400-4412
pubmed: 31010834
Aging (Albany NY). 2020 Dec 8;12(23):23478-23496
pubmed: 33295886
J Clin Med. 2019 Sep 19;8(9):
pubmed: 31546818
J Immunol. 2007 Jul 1;179(1):89-94
pubmed: 17579025
Front Immunol. 2018 Oct 11;9:2324
pubmed: 30364222
Immunity. 2018 Nov 20;49(5):971-986.e5
pubmed: 30413361
Front Immunol. 2020 Aug 25;11:1903
pubmed: 32983113
Cells. 2021 Jun 29;10(7):
pubmed: 34209508
J Transl Med. 2013 Oct 20;11:262
pubmed: 24138752
Immunol Rev. 2006 Dec;214:47-55
pubmed: 17100875
Blood Adv. 2020 Apr 14;4(7):1388-1406
pubmed: 32271902
Front Immunol. 2020 Jan 29;10:3140
pubmed: 32063901
Innate Immun. 2013 Feb;19(1):76-85
pubmed: 22781631
Front Immunol. 2019 Jun 28;10:1397
pubmed: 31379803
Cytotherapy. 2017 Mar;19(3):408-418
pubmed: 28109751
Sci Rep. 2017 Jun 14;7(1):3501
pubmed: 28615725
N Engl J Med. 2020 Feb 6;382(6):545-553
pubmed: 32023374
Cancer Immunol Immunother. 2019 Aug;68(8):1317-1329
pubmed: 31312900
Cancer Epidemiol Biomarkers Prev. 1995 Jul-Aug;4(5):549-54
pubmed: 7549813
Cancer Immunol Res. 2019 Aug;7(8):1371-1380
pubmed: 31239316
Cancer Immunol Res. 2015 Nov;3(11):1207-17
pubmed: 26198985
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2886-91
pubmed: 15699323
Front Immunol. 2019 Jul 11;10:1594
pubmed: 31354733
Oncotarget. 2018 Nov 23;9(92):36492-36502
pubmed: 30559932
Scand J Immunol. 2007 Feb;65(2):126-38
pubmed: 17257217
Front Immunol. 2019 Aug 29;10:2078
pubmed: 31555287
PLoS Biol. 2006 Jan;4(1):e9
pubmed: 16366734
Immunity. 2020 Dec 15;53(6):1215-1229.e8
pubmed: 33220234
PLoS One. 2016 Jan 20;11(1):e0147186
pubmed: 26789128
Trends Immunol. 2001 Nov;22(11):633-40
pubmed: 11698225
J Exp Med. 2014 Mar 10;211(3):563-77
pubmed: 24516120
PLoS One. 2019 Feb 11;14(2):e0210495
pubmed: 30742629
Immunity. 2017 Nov 21;47(5):820-833
pubmed: 29166586
Nat Rev Cancer. 2020 Aug;20(8):437-454
pubmed: 32581320
J Immunol. 2008 Feb 1;180(3):1462-70
pubmed: 18209041
Cancers (Basel). 2020 Jun 12;12(6):
pubmed: 32545516
Leukemia. 2018 Feb;32(2):520-531
pubmed: 28725044
Cell Mol Life Sci. 2020 May;77(9):1745-1770
pubmed: 31690961
J Immunol. 2011 Jun 15;186(12):6753-61
pubmed: 21555534
Front Immunol. 2020 Jan 21;10:3038
pubmed: 32038612
Front Immunol. 2019 Jul 03;10:1502
pubmed: 31333651
Hum Reprod. 2019 Apr 1;34(4):689-701
pubmed: 30597092
Eur J Immunol. 2021 Sep;51(9):2188-2205
pubmed: 34189723
Blood. 2013 Apr 4;121(14):2669-77
pubmed: 23365458
J Immunol Res. 2020 Jan 4;2020:2045860
pubmed: 32377528
J Immunol Res. 2018 Mar 29;2018:2438598
pubmed: 29713652
Front Immunol. 2014 Aug 22;5:394
pubmed: 25202308
Oncotarget. 2020 Jun 30;11(26):2571-2585
pubmed: 32655841
Immunity. 2021 Jun 8;54(6):1320-1337.e4
pubmed: 33945787
J Immunother Cancer. 2021 Apr;9(4):
pubmed: 33883258
Cell Stem Cell. 2014 Apr 3;14(4):486-499
pubmed: 24702997
Front Immunol. 2021 Jan 25;11:586126
pubmed: 33569050
Immunol Rev. 2016 May;271(1):260-75
pubmed: 27088920
J Immunol. 2009 Aug 1;183(3):1789-96
pubmed: 19587011
Oncogene. 2016 Nov 17;35(46):5931-5941
pubmed: 27086930
Nat Immunol. 2016 Jun 21;17(7):790-4
pubmed: 27328009
Cancer. 2008 Feb 15;112(4):863-75
pubmed: 18203207
Cell Mol Immunol. 2020 Jul;17(7):705-711
pubmed: 32503998
Cold Spring Harb Perspect Biol. 2017 Jun 1;9(6):
pubmed: 28108486
Blood. 2001 May 15;97(10):3146-51
pubmed: 11342442
Sci Rep. 2019 Mar 14;9(1):4487
pubmed: 30872676
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3378-83
pubmed: 17360654
Sci Immunol. 2018 Nov 2;3(29):
pubmed: 30389798
Oncotarget. 2015 May 30;6(15):13835-43
pubmed: 26079948
Cancer Cell. 2017 Aug 14;32(2):135-154
pubmed: 28810142
Front Immunol. 2021 Aug 26;12:728291
pubmed: 34512661
EBioMedicine. 2020 Sep;59:102975
pubmed: 32853984
J Clin Invest. 2011 Sep;121(9):3609-22
pubmed: 21841316
Nat Immunol. 2017 Sep;18(9):995-1003
pubmed: 28759002
Immunity. 2013 Apr 18;38(4):769-81
pubmed: 23453631
Cancer Immunol Immunother. 2021 Aug;70(8):2125-2138
pubmed: 33449132
Immunity. 2017 Jan 17;46(1):148-161
pubmed: 27986455
Sci Signal. 2016 Feb 16;9(415):ra19
pubmed: 26884601
Immunity. 2012 Jan 27;36(1):55-67
pubmed: 22261438
Nat Med. 2006 Sep;12(9):1065-74
pubmed: 16892062
Nat Immunol. 2020 Aug;21(8):835-847
pubmed: 32690952
Nat Immunol. 2017 Sep;18(9):1004-1015
pubmed: 28759001
FASEB J. 2018 Oct;32(10):5365-5377
pubmed: 29763380
Transl Oncol. 2021 Jan;14(1):100930
pubmed: 33186888
Blood. 2005 Mar 1;105(5):2082-9
pubmed: 15536146
Nat Rev Cancer. 2013 Nov;13(11):788-99
pubmed: 24132110
J Immunol. 2007 Apr 15;178(8):4947-55
pubmed: 17404276
Front Immunol. 2020 Dec 16;11:607131
pubmed: 33391277
J Immunol. 2020 Jun 15;204(12):3171-3181
pubmed: 32332109
Int Immunopharmacol. 2013 Oct;17(2):198-204
pubmed: 23806302
Proc Natl Acad Sci U S A. 2021 Jul 13;118(28):
pubmed: 34244432
Front Immunol. 2015 Feb 02;6:31
pubmed: 25699048
Cell. 2018 Feb 22;172(5):1022-1037.e14
pubmed: 29429633
Nat Med. 2003 Oct;9(10):1269-74
pubmed: 14502282
Trends Immunol. 2020 Oct;41(10):902-917
pubmed: 32917510